Pazopanib in patients with metastatic renal cell carcinoma previously treated with sunitinib or bevacizumab: A Sarah Cannon Research Institute phase II trial.
J. A. Reeves
No relevant relationships to disclose
D. R. Spigel
No relevant relationships to disclose
D. B. Daniel
No relevant relationships to disclose
E. K. Friedman
No relevant relationships to disclose
H. A. Burris
No relevant relationships to disclose
J. D. Hainsworth
No relevant relationships to disclose